As the respiratory illness season begins, cases of respiratory syncytial virus (RSV) cases are rising in Canada. But new tools offers hope for prevention.

Thanks to the introduction of new monoclonal antibodies and vaccines. The respiratory syncytial virus (RSV) prophylaxis ...

In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from ...